Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, Uganda.

Mahan CS, Zalwango S, Thiel BA, Malone LL, Chervenak KA, Baseke J, Dobbs D, Stein CM, Mayanja H, Joloba M, Whalen CC, Boom WH.

Am J Trop Med Hyg. 2012 Apr;86(4):690-7. doi: 10.4269/ajtmh.2012.11-0553.

2.

Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda.

Ma N, Zalwango S, Malone LL, Nsereko M, Wampande EM, Thiel BA, Okware B, Igo RP Jr, Joloba ML, Mupere E, Mayanja-Kizza H, Boom WH, Stein CM; Tuberculosis Research Unit (TBRU).

BMC Infect Dis. 2014 Jun 27;14:352. doi: 10.1186/1471-2334-14-352.

3.

Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.

Buchwald UK, Adetifa IM, Bottomley C, Owiafe PK, Donkor S, Bojang AL, Sutherland JS.

PLoS One. 2014 Dec 30;9(12):e116268. doi: 10.1371/journal.pone.0116268. eCollection 2014.

4.

Whole blood interferon-gamma responses to mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda.

Lewinsohn DA, Zalwango S, Stein CM, Mayanja-Kizza H, Okwera A, Boom WH, Mugerwa RD, Whalen CC.

PLoS One. 2008;3(10):e3407. doi: 10.1371/journal.pone.0003407. Epub 2008 Oct 15.

5.

Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda.

Whalen CC, Chiunda A, Zalwango S, Nshuti L, Jones-Lopez E, Okwera A, Hirsch C, Peters P, Boom WH, Mugerwa RD.

Am J Trop Med Hyg. 2006 Jul;75(1):55-61.

6.

Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.

Johnson DF, Malone LL, Zalwango S, Mukisa Oketcho J, Chervenak KA, Thiel B, Mayanja-Kizza H, Stein CM, Boom WH, Lancioni CL; Tuberculosis Research Unit.

PLoS One. 2014 May 5;9(5):e96613. doi: 10.1371/journal.pone.0096613. eCollection 2014.

7.

Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.

Silva LC, Silveira GG, Arnone M, Romiti R, Geluk A, Franken KC, Duarte AJ, Takahashi MD, Benard G.

Arch Dermatol Res. 2010 May;302(4):255-62. doi: 10.1007/s00403-009-0982-2. Epub 2009 Jul 16.

PMID:
19609541
8.
9.

The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.

Biraro IA, Kimuda S, Egesa M, Cose S, Webb EL, Joloba M, Smith SG, Elliott AM, Dockrell HM, Katamba A.

PLoS One. 2016 Jan 15;11(1):e0146098. doi: 10.1371/journal.pone.0146098. eCollection 2016.

10.
11.

Vdelta2+ gammadelta T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay.

Rojas RE, Chervenak KA, Thomas J, Morrow J, Nshuti L, Zalwango S, Mugerwa RD, Thiel BA, Whalen CC, Boom WH.

J Infect Dis. 2005 Nov 15;192(10):1806-14. Epub 2005 Oct 12.

12.

Genome scan of M. tuberculosis infection and disease in Ugandans.

Stein CM, Zalwango S, Malone LL, Won S, Mayanja-Kizza H, Mugerwa RD, Leontiev DV, Thompson CL, Cartier KC, Elston RC, Iyengar SK, Boom WH, Whalen CC.

PLoS One. 2008;3(12):e4094. doi: 10.1371/journal.pone.0004094. Epub 2008 Dec 31.

13.

Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.

Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A.

Am J Respir Crit Care Med. 2008 May 15;177(10):1164-70. doi: 10.1164/rccm.200711-1613OC. Epub 2008 Feb 14.

PMID:
18276940
14.

Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis.

Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A.

Am J Respir Crit Care Med. 2006 Oct 1;174(7):831-9. Epub 2006 Jun 23.

PMID:
16799072
15.

IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia.

del Corral H, París SC, Marín ND, Marín DM, López L, Henao HM, Martínez T, Villa L, Barrera LF, Ortiz BL, Ramírez ME, Montes CJ, Oquendo MC, Arango LM, Riaño F, Aguirre C, Bustamante A, Belisle JT, Dobos K, Mejía GI, Giraldo MR, Brennan PJ, Robledo J, Arbeláez MP, Rojas CA, García LF.

PLoS One. 2009 Dec 14;4(12):e8257. doi: 10.1371/journal.pone.0008257.

16.

Biomarker changes associated with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts.

Hussain R, Talat N, Shahid F, Dawood G.

PLoS One. 2009 Oct 14;4(10):e7444. doi: 10.1371/journal.pone.0007444.

17.

Highly discordant T cell responses in individuals with recent exposure to household tuberculosis.

Hesseling AC, Mandalakas AM, Kirchner HL, Chegou NN, Marais BJ, Stanley K, Zhu X, Black G, Beyers N, Walzl G.

Thorax. 2009 Oct;64(10):840-6. doi: 10.1136/thx.2007.085340. Epub 2008 Aug 5.

PMID:
18682523
18.

Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.

Kobashi Y, Shimizu H, Ohue Y, Mouri K, Obase Y, Miyashita N, Oka M.

Lung. 2010 Aug;188(4):283-7. doi: 10.1007/s00408-010-9238-3. Epub 2010 Apr 27.

19.

Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.

Hasan Z, Jamil B, Ashraf M, Islam M, Dojki M, Irfan M, Hussain R.

Clin Vaccine Immunol. 2009 Jul;16(7):991-8. doi: 10.1128/CVI.00091-09. Epub 2009 May 13.

Supplemental Content

Support Center